MaxCyte, Inc. (MXCT) Operating cash flow 2019–2025
MaxCyte, Inc. (MXCT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$34.4MFY2025 · since FY2019: -$8.8M → -$34.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$34.4M | -24.6% |
| FY2024 | -$27.6M | -27.3% |
| FY2023 | -$21.7M | -46.7% |
| FY2022 | -$14.8M | -38.4% |
| FY2021 | -$10.7M | -21.6% |
| FY2020 | -$8.8M | +0.2% |
| FY2019 | -$8.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MXCT financial trends
MXCT RevenueMXCT Net incomeMXCT Net marginMXCT Gross profitMXCT Gross marginMXCT Operating incomeMXCT Operating marginMXCT Free cash flowMXCT Capital expendituresMXCT Return on equityMXCT Stock buybacksMXCT Dividends paidMXCT Total assetsMXCT Total liabilitiesMXCT Shareholders’ equityMXCT overview →